Skip to main content
. Author manuscript; available in PMC: 2018 Oct 19.
Published in final edited form as: AIDS Care. 2017 Aug 21;30(1):47–55. doi: 10.1080/09540121.2017.1360997

Table 2.

HIV test uptake overall and by intervention status under intent-to-treat (i.e., by randomization assignment) and per protocol (i.e., by what was actually offered).

Total, n (%) SOC arm, n (%) Choice arm, n (%) Mantel Haenszel OR (95% CI) adjusting for strata Mantel Haenszel p-value
Total as randomized 305 (100%) 155 (50.8%) 150 (49.2%) NA NA
Total per protocol 305 (100%) 156 (51.1%) 149 (48.9%) NA NA
Tested in clinic (intent-to-treat analysis)
 Yes 233 (76.4%) 113 (72.9%) 120 (80.0%) 1.5 (0.9–2.7) 0.189
 No 72 (23.5%) 42 (27.1%) 30 (20.0%) NA NA
Tested in clinic (per protocol analysis)a
 Yes 233 (76.4%) 114 (73.1%) 119 (79.9%) 1.5 (0.9–2.7) 0.196
 No 72 (23.6%) 42 (26.9%) 30 (20.1%) NA NA
Tested either in clinic or took test kit for home use (intent-to-treat analysis)
 Yes 244 (80.0%) 113 (72.9%) 131 (87.3%) 2.8 (1.5–5.4) 0.002
 No 61 (20.0%) 42 (27.1%) 19 (12.7%)
Tested either in clinic or took test kit for home use (per protocol analysis)a
 Yes 244 (80.0%) 114 (73.1%) 130 (87.2%) 2.8 (1.5–5.4) 0.002
 No 61 (20.0%) 42 (26.9%) 19 (12.8%) NA NA
a

One participant in the choice arm was only offered the SOC HIV test.